{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:56:32Z","timestamp":1791618992447,"version":"4.3.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T00:00:00Z","timestamp":1647820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jphs.2022.03.003","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T21:35:15Z","timestamp":1648244115000},"page":"53-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Protective effects of tadalafil on damaged podocytes in an adriamycin-induced nephrotic syndrome model"],"prefix":"10.1016","volume":"149","author":[{"given":"Natsumi","family":"Tomita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9474-7775","authenticated-orcid":false,"given":"Yuji","family":"Hotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Naiki-Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akimasa","family":"Sanagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Furukawa-Hibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphs.2022.03.003_bib1","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41573-021-00242-0","article-title":"The glomerular filtration barrier: a structural target for novel kidney therapies","volume":"20","author":"Daehn","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jphs.2022.03.003_bib2","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1046\/j.1523-1755.2003.00868.x","article-title":"Proteinuria and the risk of developing end-stage renal disease","volume":"63","author":"Iseki","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.jphs.2022.03.003_bib3","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ekir.2020.10.033","article-title":"Scottish Renal Biopsy Registry. A National registry study of patient and renal survival in adult nephrotic syndrome","volume":"6","author":"Kolb","year":"2020","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.jphs.2022.03.003_bib4","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 Clinical practice guideline for the management of glomerular diseases","volume":"100","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.jphs.2022.03.003_bib5","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00467-010-1692-x","article-title":"Pathogenesis and therapy of focal segmental glomerulosclerosis: an update","volume":"26","author":"Gbadegesin","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jphs.2022.03.003_bib6","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s10157-015-1216-x","article-title":"Evidence-based clinical practice guidelines for nephrotic syndrome 2014","volume":"20","author":"Nishi","year":"2016","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.jphs.2022.03.003_bib7","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/ki.2012.280","article-title":"KDIGO Clinical Practice guideline for glomerulonephritis","volume":"82","author":"Radhakrishnan","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.jphs.2022.03.003_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"7","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.jphs.2022.03.003_bib9","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20203248","article-title":"NPHS2 gene polymorphism aggravates renal damage caused by focal segmental glomerulosclerosis with COL4A3 mutation","volume":"41","author":"Sun","year":"2021","journal-title":"Biosci Rep"},{"key":"10.1016\/j.jphs.2022.03.003_bib10","doi-asserted-by":"crossref","first-page":"e42068","DOI":"10.7554\/eLife.42068","article-title":"Analysis of the genomic architecture of a complex trait locus in hypertensive rat models links Tmem63c to kidney damage","volume":"8","author":"Schulz","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.jphs.2022.03.003_bib11","doi-asserted-by":"crossref","first-page":"e0241745","DOI":"10.1371\/journal.pone.0241745","article-title":"In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease","volume":"15","author":"da Silva","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jphs.2022.03.003_bib12","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41374-020-00503-3","article-title":"Nuclear exclusion of YAP exacerbates podocyte apoptosis and disease progression in Adriamycin-induced focal segmental glomerulosclerosis","volume":"101","author":"Zhuang","year":"2021","journal-title":"Lab Invest"},{"key":"10.1016\/j.jphs.2022.03.003_bib13","first-page":"e86177","article-title":"A\u00a0flexible, multilayered protein scaffold maintains the slit in between glomerular podocytes","volume":"1","author":"Grahammer","year":"2016","journal-title":"JCI Insight Imaging"},{"key":"10.1016\/j.jphs.2022.03.003_bib14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3390\/ijms20030519","article-title":"Kidney injury by variants in the COL4A5 gene aggravated by polymorphisms in slit diaphragm genes causes focal segmental glomerulosclerosis","volume":"20","author":"Frese","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jphs.2022.03.003_bib15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1681\/ASN.2020081109","article-title":"Dysregulated Dynein-mediated trafficking of Nephrin causes INF2-related podocytopathy","volume":"32","author":"Sun","year":"2021","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jphs.2022.03.003_bib16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41572-020-0196-7","article-title":"Podocytopathies","volume":"6","author":"Kopp","year":"2020","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.jphs.2022.03.003_bib17","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1053\/j.ackd.2014.05.009","article-title":"The pathogenesis of focal segmental glomerulosclerosis","volume":"21","author":"Jefferson","year":"2014","journal-title":"Adv Chron Kidney Dis"},{"key":"10.1016\/j.jphs.2022.03.003_bib18","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1681\/ASN.2005010055","article-title":"Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene","volume":"16","author":"Wharram","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jphs.2022.03.003_bib19","first-page":"e14556","article-title":"The phosphodiesterase 5 inhibitor tadalafil has renoprotective effects in a rat model of chronic kidney disease","volume":"8","author":"Tomita","year":"2020","journal-title":"Phys Rep"},{"key":"10.1016\/j.jphs.2022.03.003_bib20","doi-asserted-by":"crossref","first-page":"F921","DOI":"10.1152\/ajprenal.00641.2017","article-title":"Mechanical challenges and cytoskeletal impairments in focal segmental glomerulosclerosis","volume":"314","author":"Feng","year":"2018","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.jphs.2022.03.003_bib21","doi-asserted-by":"crossref","first-page":"573557","DOI":"10.3389\/fphar.2020.573557","article-title":"Glomerular endothelial cells as instigators of glomerular sclerotic diseases","volume":"11","author":"Sol","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jphs.2022.03.003_bib22","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1681\/ASN.2015080885","article-title":"Sildenafil prevents podocyte injury via PPAR- \u03b3-mediated TRPC6 inhibition","volume":"28","author":"Sonneveld","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jphs.2022.03.003_bib23","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jphs.2022.03.003_bib24","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1681\/ASN.2007101109","article-title":"RAGE mediates podocyte injury in adriamycin-induced glomerulosclerosis","volume":"19","author":"Guo","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jphs.2022.03.003_bib25","doi-asserted-by":"crossref","first-page":"112789","DOI":"10.1016\/j.jep.2020.112789","article-title":"Tripterygium glycoside fraction n2 ameliorates adriamycin-induced nephrotic syndrome in rats by suppressing apoptosis","volume":"257","author":"Wang","year":"2020","journal-title":"J\u00a0Ethnopharmacol"},{"key":"10.1016\/j.jphs.2022.03.003_bib26","doi-asserted-by":"crossref","first-page":"41543","DOI":"10.1074\/jbc.C100452200","article-title":"Interaction with podocin facilitates nephrin signaling","volume":"276","author":"Huber","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jphs.2022.03.003_bib27","doi-asserted-by":"crossref","first-page":"11218","DOI":"10.1038\/s41598-017-10125-3","article-title":"Cinaciguat ameliorates glomerular damage by reducing ERK1\/2 activity and TGF-\u00df expression in type-1 diabetic rats","volume":"7","author":"Czirok","year":"2017","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.jphs.2022.03.003_bib28","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/jcb.22981","article-title":"Essential roles of the nitric oxide (no)\/cGMP\/protein kinase G type-I\u03b1 (PKG-I\u03b1) signaling pathway and the atrial natriuretic peptide (ANP)\/cGMP\/PKG-I\u03b1 autocrine loop in promoting proliferation and cell survival of OP9 bone marrow stromal cells","volume":"112","author":"Wong","year":"2011","journal-title":"J\u00a0Cell Biochem"},{"issue":"1\u20132","key":"10.1016\/j.jphs.2022.03.003_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000332811","article-title":"Differential contribution of the guanylyl cyclase-cyclic GMP-protein kinase G pathway to the proliferation of\u00a0neural stem cells stimulated by nitric oxide","volume":"21","author":"Carreira","year":"2013","journal-title":"Neurosignals"},{"issue":"7","key":"10.1016\/j.jphs.2022.03.003_bib30","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3390\/molecules24071376","article-title":"KMUP-1 ameliorates ischemia-induced cardiomyocyte apoptosis through the NO\u207bcGMP\u207bMAPK signaling pathways","volume":"24","author":"Meng-Luen","year":"2019","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.jphs.2022.03.003_bib31","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.bbadis.2017.11.023","article-title":"Melatonin protects diabetic heart against ischemia-reperfusion injury, role of membrane receptor-dependent cGMP-PKG activation","volume":"1864","author":"Li-Ming","year":"2018","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"issue":"43","key":"10.1016\/j.jphs.2022.03.003_bib32","doi-asserted-by":"crossref","first-page":"29572","DOI":"10.1074\/jbc.M801547200","article-title":"Protein kinase G-dependent cardioprotective mechanism of phosphodiesterase-5 inhibition involves phosphorylation of ERK and GSK3beta","volume":"283","author":"Das","year":"2008","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"10.1016\/j.jphs.2022.03.003_bib33","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/j.1523-1755.2005.00569.x","article-title":"CREB mediates ERK-induced survival of mouse renal tubular cells after oxidant stress","volume":"68","author":"Arany","year":"2005","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.jphs.2022.03.003_bib34","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/sj.bjp.0705277","article-title":"Effect of sildenafil on cyclic nucleotide phosphodiesterase activity, vascular tone and calcium signaling in rat pulmonary artery","volume":"139","author":"Pauvert","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jphs.2022.03.003_bib35","doi-asserted-by":"crossref","first-page":"912","DOI":"10.2215\/CJN.11971116","article-title":"Albuminuria, proteinuria, and renal disease progression in children with CKD","volume":"12","author":"Fuhrman","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jphs.2022.03.003_bib36","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/ndt\/gfs391","article-title":"Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes","volume":"28","author":"Fang","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jphs.2022.03.003_bib37","doi-asserted-by":"crossref","first-page":"119506","DOI":"10.1016\/j.lfs.2021.119506","article-title":"Phosphodiesterase (1, 3 & 5) inhibitors attenuate diclofenac-induced acute kidney toxicity in rats","volume":"277","author":"Wadie","year":"2021","journal-title":"Life Sci"},{"issue":"6953","key":"10.1016\/j.jphs.2022.03.003_bib38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nature01914","article-title":"Structure of the catalytic domain of human phosphodiesterase 5 with bound drug molecules","volume":"425","author":"Byung-Je","year":"2003","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.jphs.2022.03.003_bib39","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.2174\/092986708784911524","article-title":"Structure -activity relationships of PDE5 inhibitors","volume":"15","author":"Eros","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jphs.2022.03.003_bib40","doi-asserted-by":"crossref","first-page":"111128","DOI":"10.1016\/j.biopha.2020.111128","article-title":"Phosphodiesterase 5 (PDE5): structure-function regulation and therapeutic applications of inhibitors","volume":"134","author":"Ahmed","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jphs.2022.03.003_bib41","doi-asserted-by":"crossref","first-page":"1631735","DOI":"10.1155\/2020\/1631735","article-title":"The effect of grapefruit juice on the pharmacokinetics of tadalafil in rats","author":"Shen","year":"2020","journal-title":"BioMed Res Int"},{"issue":"3","key":"10.1016\/j.jphs.2022.03.003_bib42","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2125.2005.02553.x","article-title":"Tadalafil pharmacokinetics in healthy subjects","volume":"61","author":"Forgue","year":"2006","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.jphs.2022.03.003_bib43","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2125.2006.02726.x","article-title":"Effects of gender, age, diabetes mellitus and renal and hepatic impairment on tadalafil pharmacokinetics","volume":"63","author":"Forgue","year":"2007","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.jphs.2022.03.003_bib44","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1080\/0886022X.2019.1669459","article-title":"Impact of pretreatment with carnitine and tadalafil on contrast-induced nephropathy in CKD patients","volume":"41","author":"Armaly","year":"2019","journal-title":"Ren Fail"},{"issue":"1","key":"10.1016\/j.jphs.2022.03.003_bib45","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.diabres.2007.02.006","article-title":"Sildenafil citrate diminishes microalbuminuria and the percentage of A1c in male patients with type 2 diabetes","volume":"78","author":"Grover-P\u00e1ez","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"issue":"11","key":"10.1016\/j.jphs.2022.03.003_bib46","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1681\/ASN.2015050473","article-title":"Phosphodiesterase type 5 inhibition reduces albuminuria in subjects with overt diabetic nephropathy","volume":"27","author":"Scheele","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861322000238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861322000238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:02:04Z","timestamp":1761163324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861322000238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1347861322000238"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2022.03.003","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effects of tadalafil on damaged podocytes in an adriamycin-induced nephrotic syndrome model","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2022.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}